For most of the GLP-1 era, the deal was simple: the effective options were injections, and the one daily pill came wrapped in rules. Foundayo changes that deal. Approved by the FDA in 2026, it is the first once-daily small-molecule GLP-1 pill, and its headline practical feature is what it does not ask of you: no empty stomach, no water limits, no waiting half an hour before breakfast.
This guide covers what Foundayo (orforglipron) actually is, how a small-molecule pill differs from the peptide GLP-1s you already know, what the approval covers, and what a good daily tracking routine looks like, including how to track Foundayo in our app today.
What Foundayo is
Foundayo is Eli Lilly's brand name for orforglipron, a GLP-1 receptor agonist taken as a pill once a day. As of September 2026 it is FDA approved for adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. It reached that approval unusually fast, moving through review under the FDA's national priority voucher pilot.
What makes it a genuine first is the chemistry. Every other GLP-1 receptor agonist on the market, from the weekly injections to Rybelsus, is a peptide: a chain of amino acids related to the gut hormone the class is named after. Orforglipron is a small molecule, conventional pharmaceutical chemistry rather than a modified hormone. It activates the same GLP-1 receptor, but it gets there by a different route.
Why "small molecule" matters in daily life
Peptides are fragile in the digestive tract, which is why nearly all GLP-1 medications are injections. Rybelsus, the one older oral option, only works because of a careful workaround, and that workaround is exactly where its famous rules come from: empty stomach, plain water only (up to about 4 ounces), then a wait of at least 30 minutes before food, drink or other oral medications. The rules are not bureaucratic caution; they are what makes a peptide survive swallowing. Our guide to tracking Rybelsus covers that morning ritual in detail.
A small molecule does not need the workaround. Foundayo can be taken at any time of day with no food or water restrictions, which is its headline practical difference. The pill slots into whatever routine you already have: with breakfast, with your other morning medications, or at night. For anyone who found the Rybelsus ritual to be the hardest part of the medication, that difference is the entire story.
Dosing: once daily, climbed in steps
Like the rest of the class, Foundayo is not taken at full strength from day one. Per the label, dosing is once daily and titrated upward in steps over time, the same slow-climb logic that governs every GLP-1: give the body, and especially the gut, time to adjust before the next increase. We are deliberately not listing specific milligram amounts, prices or availability details here; those specifics belong to the official labeling and to your prescriber. If you want to understand why every medication in this class climbs a ladder, our guide to GLP-1 titration schedules explains the pattern.
What you should expect, practically, is familiar to anyone who has read about the injectables: a starting dose that is about acclimation rather than full effect, stepwise increases decided by your prescriber, and the likelihood that common side effects such as nausea cluster around the increases and fade as your body settles, per the labels for this class. When and whether you climb is your prescriber's call, never the app's and never this article's.
What daily tracking looks like
A daily pill changes the shape of tracking. A weekly injection is an event; you remember it the way you remember an appointment. A daily pill is a habit, and habits fail quietly: not with a dramatic missed week but with a "did I take it this morning?" moment at 4 pm. The tracking routine that works is correspondingly small:
- Log the dose at the moment you take it, one tap, so the "did I take it?" question always has an answer.
- A daily reminder at your chosen time, because with no food or water rules the best time is simply the one you will not skip.
- A short appetite or energy note a few times a week, which is what makes the eventual prescriber conversation concrete.
- Weight, protein and water in the same place, since appetite suppression quietly puts protein and hydration at risk on any GLP-1.
- A side effect entry with severity when something is off, especially in the weeks after a dose step.
That is a two-minute daily routine, and the two minutes matter more on a daily medication than a weekly one because adherence is the whole game. Our guide to what to log every day on a GLP-1 makes the case for keeping it exactly this small.
One habit deserves special mention on a pill with no timing rules: anchoring. Precisely because Foundayo does not force a ritual the way Rybelsus does, it is easy for the dose to float around the day until it floats out of it. Pick an anchor that already happens daily, brushing your teeth, the first coffee, plugging in your phone at night, and attach the pill and the one-tap log to it. The label gives you the freedom to choose any time; the habit science says choose one and keep it.
Tracking Foundayo in GLP 1 Tracker App today
The app ships a dedicated Foundayo preset with the label’s dose steps built in. Pick Foundayo, set the step your prescriber assigned, and it behaves like any built-in medication: daily reminders and overdue alerts, a one-tap dose log, the side effect diary, and weight, protein, water and fiber alongside. Everything stays on your phone, with no account, no server and no data collection.
If you started tracking with the custom oral option before the preset existed, that history still counts; switch your medication to the Foundayo preset and keep logging without missing a day.
Is Foundayo right for you?
That is not a question a tracking app can answer, and we will not pretend otherwise. Whether a daily small-molecule pill fits your treatment better than a weekly injection or oral semaglutide depends on your health history, your insurance reality, and your prescriber's judgment. What we can say is the general truth of this class: whichever GLP-1 you and your clinician choose, the people who do best tend to be the ones who take it consistently, notice patterns early, and show up to appointments with real data instead of vague recollections. That part is the same for a pill as for a pen.
GLP 1 Tracker AppFree on the App Store. A dedicated Foundayo preset: daily reminders, dose history, side effects, and everything stays on your phone.
Get the app
Frequently asked questions
Is Foundayo FDA approved?
Yes. As of September 2026, Foundayo (orforglipron) is FDA approved and available in the United States, cleared in April 2026 for adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. It moved through review unusually fast under the FDA's national priority voucher pilot. For current status and full details, check the official labeling and talk to your prescriber.
Do I have to take Foundayo on an empty stomach like Rybelsus?
No. Foundayo's headline practical difference is that it can be taken at any time of day with no food or water restrictions. Rybelsus, by contrast, requires an empty stomach, plain water only, up to about 4 ounces, and a wait of at least 30 minutes before eating, drinking or taking other oral medications. As always, follow your own product's label and your prescriber's instructions.
How is Foundayo different from Rybelsus?
Both are daily GLP-1 pills, but they are built differently. Rybelsus is oral semaglutide, a peptide that survives digestion only under strict conditions, which is where its empty-stomach rules come from. Foundayo is orforglipron, a small molecule rather than a peptide, so it is absorbed like a conventional pill and carries no food or water restrictions. Which one fits your treatment is a conversation for your prescriber.
What is the dose of Foundayo?
Foundayo is taken once daily, and per the label the dose is titrated upward in steps over time, the same slow-climb pattern used across the GLP-1 class to help the body adjust. We deliberately do not list specific milligram amounts here: dose specifics belong to the official labeling and to your prescriber, who decides where you start, when you step up, and where you settle.
Can I track Foundayo in GLP 1 Tracker App?
Yes. The app includes a dedicated Foundayo preset with the once-daily schedule and the label’s dose steps built in. Pick it, set the step your prescriber assigned, and you get daily reminders, a one-tap dose log, the side effect diary and weight tracking, with everything stored on your phone, no account and no data collection.